Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potential

Cell Communication and Signaling

Volumn 12, Issue 1, 2014, Pages

  Lopatina, Tatiana ^a   Bruno, Stefania ^a   Tetta, Ciro ^b   Kalinina, Natalia ^c   Porta, Massimo ^a   Camussi, Giovanni ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b FRESENIUS MEDICAL CARE   (Germany)

^c MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Adipose mesenchymal stem cells; Angiogenesis; Extracellular vesicles; PDGF

Indexed keywords

MATRIX METALLOPROTEINASE; PLATELET DERIVED GROWTH FACTOR; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR;

ADIPOSE MESENCHYMAL STEM CELL; ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CELL INVASION; CELL ORGANELLE; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR VESICLE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; MALE; MESENCHYMAL STEM CELL; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN FUNCTION; ADIPOSE TISSUE; ADULT STEM CELL; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; EXOCYTOSIS; EXOSOME; METABOLISM; MICROVASCULATURE; MULTIPOTENT STEM CELL; SCID MOUSE;

MUS;

ADIPOSE TISSUE; ADULT STEM CELLS; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; ENDOTHELIAL CELLS; EXOCYTOSIS; EXOSOMES; HUMANS; MICE; MICE, SCID; MICROVESSELS; MULTIPOTENT STEM CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; PLATELET-DERIVED GROWTH FACTOR;

EID: 84899585740     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/1478-811X-12-26     Document Type: Article

References (59)

1. Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells. Cantaluppi V, Gatti S, Medica D, Figliolini F, Bruno S, Deregibus MC, Sordi A, Biancone L, Tetta C, Camussi G, Kidney Int 2012 82 4 412 427 10.1038/ki.2012.105 22495296
2. The emerging role of microvesicles in cellular therapies for organ/tissue regeneration. Ratajczak MZ, Nephrol Dial Transplant 2011 26 5 1453 1456 10.1093/ndt/gfr165 21531733
3. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, Collino F, Morando L, Busca A, Falda M, Bussolati B, Tetta C, Camussi G, J Am Soc Nephrol 2009 20 5 1053 1067 10.1681/ASN.2008070798 19389847
4. Membrane vesicles as conveyors of immune responses. Thery C, Ostrowski M, Segura E, Nat Rev Immunol 2009 9 8 581 593 10.1038/nri2567 19498381
5. Paracrine/endocrine mechanism of stem cells on kidney repair: role of microvesicle-mediated transfer of genetic information. Camussi G, Deregibus MC, Tetta C, Curr Opin Nephrol Hypertens 2010 19 1 7 12 10.1097/MNH.0b013e328332fb6f 19823086
6. Adipose stromal cells stimulate angiogenesis via promoting progenitor cell differentiation, secretion of angiogenic factors, and enhancing vessel maturation. Rubina K, Kalinina N, Efimenko A, Lopatina T, Melikhova V, Tsokolaeva Z, Sysoeva V, Tkachuk V, Parfyonova Y, Tissue Eng Part A 2009 15 8 2039 2050 10.1089/ten.tea.2008.0359 19368510
7. Adipose-derived stem cells stimulate regeneration of peripheral nerves: BDNF secreted by these cells promotes nerve healing and axon growth de novo. Lopatina T, Kalinina N, Karagyaur M, Stambolsky D, Rubina K, Revischin A, Pavlova G, Parfyonova Y, Tkachuk V, PLoS One 2011 6 3 17899 10.1371/journal. pone.0017899 21423756
8. The use of adipose-derived stem cells as sheets for wound healing. McLaughlin MM, Marra KG, Organogenesis 2013 9 2 79 81 10.4161/org.24946 23764648
9. Adipose-derived stem cells for wound healing applications. Cherubino M, Rubin JP, Miljkovic N, Kelmendi-Doko A, Marra KG, Ann Plast Surg 2011 66 2 210 215 10.1097/SAP.0b013e3181e6d06c 21200308
10. IFATS collection: the conditioned media of adipose stromal cells protect against hypoxia-ischemia-induced brain damage in neonatal rats. Wei X, Du Z, Zhao L, Feng D, Wei G, He Y, Tan J, Lee WH, Hampel H, Dodel R, Johnstone BH, March KL, Farlow MR, Du Y, Stem Cells 2009 27 2 478 488 10.1634/stemcells.2008- 0333 19023032
11. Comparative immunomodulatory properties of adipose-derived mesenchymal stem cells conditioned media from BALB/c, C57BL/6, and DBA mouse strains. Hashemi SM, Hassan ZM, Pourfathollah AA, Soudi S, Shafiee A, Soleimani M, J Cell Biochem 2013 114 4 955 965 10.1002/jcb.24437 23225199
12. Role of mesenchymal stem cell-derived microvesicles in tissue repair. Bruno S, Camussi G, Pediatr Nephrol 2013 23 12 2249 2254
13. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Deregibus MC, Cantaluppi V, Calogero R, Lo Iacono M, Tetta C, Biancone L, Bruno S, Bussolati B, Camussi G, Blood 2007 110 7 2440 2448 10.1182/blood-2007-03-078709 17536014 (Pubitemid 47523165)
14. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Hellstrom M, Kalen M, Lindahl P, Abramsson A, Betsholtz C, Development 1999 126 14 3047 3055 10375497 (Pubitemid 29378170)
15. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Leveen P, Pekny M, Gebre-Medhin S, Swolin B, Larsson E, Betsholtz C, Genes Dev 1994 8 16 1875 1887 10.1101/gad.8.16.1875 7958863 (Pubitemid 24273888)
16. Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Soriano P, Genes Dev 1994 8 16 1888 1896 10.1101/gad.8.16.1888 7958864
17. PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors. Battegay EJ, Rupp J, Iruela-Arispe L, Sage EH, Pech M, J Cell Biol 1994 125 4 917 928 10.1083/jcb.125.4.917 7514607 (Pubitemid 24151185)
18. Platelet-derived growth factor indirectly stimulates angiogenesis in vitro. Sato N, Beitz JG, Kato J, Yamamoto M, Clark JW, Calabresi P, Raymond A, Frackelton AR Jr, Am J Pathol 1993 142 4 1119 1130 7682762 (Pubitemid 24060588)
19. Role of platelet-derived growth factor in wound healing. Pierce GF, Mustoe TA, Altrock BW, Deuel TF, Thomason A, J Cell Biochem 1991 45 4 319 326 10.1002/jcb.240450403
20. Tumor cell-derived PDGF-B potentiates mouse mesenchymal stem cells-pericytes transition and recruitment through an interaction with NRP-1. Dhar K, Dhar G, Majumder M, Haque I, Mehta S, Van Veldhuizen PJ, Banerjee SK, Banerjee S, Mol Cancer 2010 9 209 10.1186/1476-4598-9-209 20687910
21. Platelet-derived growth factor receptors regulate mesenchymal stem cell fate: implications for neovascularization. Ball SG, Shuttleworth CA, Kielty CM, Expert Opin Biol Ther 2010 10 1 57 71 10.1517/14712590903379510 20078229
22. ARTEMIN promotes de novo angiogenesis in ER negative mammary carcinoma through activation of TWIST1-VEGF-A signalling. Banerjee A, Wu ZS, Qian PX, Kang J, Liu DX, Zhu T, Lobie PE, PLoS One 2012 7 11 50098 10.1371/journal.pone. 0050098 23185544
23. Axl is essential for VEGF-A-dependent activation of PI3K/Akt. Ruan GX, Kazlauskas A, EMBO J 2012 31 7 1692 1703 10.1038/emboj.2012.21 22327215
24. Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis. Li Y, Ye X, Tan C, Hongo JA, Zha J, Liu J, Kallop D, Ludlam MJ, Pei L, Oncogene 2009 28 39 3442 3455 10.1038/onc.2009.212 19633687
25. Lactadherin promotes VEGF-dependent neovascularization. Silvestre JS, Thery C, Hamard G, Boddaert J, Aguilar B, Delcayre A, Houbron C, Tamarat R, Blanc-Brude O, Heeneman S, Clergue M, Duriez M, Merval R, Levy B, Tedgui A, Amigorena S, Mallat Z, Nat Med 2005 11 5 499 506 10.1038/nm1233 15834428 (Pubitemid 40685972)
26. Osteoprotegerin is an alpha vbeta 3-induced, NF-kappa B-dependent survival factor for endothelial cells. Malyankar UM, Scatena M, Suchland KL, Yun TJ, Clark EA, Giachelli CM, J Biol Chem 2000 275 28 20959 20962 10.1074/jbc.C000290200 10811631 (Pubitemid 30481782)
27. Osteoprotegerin (OPG)-a potential new role in the regulation of endothelial cell phenotype and tumour angiogenesis? Cross SS, Yang Z, Brown NJ, Balasubramanian SP, Evans CA, Woodward JK, Neville-Webbe HL, Lippitt JM, Reed MW, Coleman RE, Holen I, Int J Cancer 2006 118 8 1901 1908 10.1002/ijc.21606 16287088
28. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells. Tamura K, Hashimoto K, Suzuki K, Yoshie M, Kutsukake M, Sakurai T, Eur J Pharmacol 2009 610 1-3 61 67 19374835
29. Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis. Rusnati M, Camozzi M, Moroni E, Bottazzi B, Peri G, Indraccolo S, Amadori A, Mantovani A, Presta M, Blood 2004 104 1 92 99 10.1182/blood-2003-10-3433 15031207 (Pubitemid 38879843)
30. Secreted frizzled-related protein 4: an angiogenesis inhibitor. Muley A, Majumder S, Kolluru GK, Parkinson S, Viola H, Hool L, Arfuso F, Ganss R, Dharmarajan A, Chatterjee S, Am J Pathol 2010 176 3 1505 1516 10.2353/ajpath.2010.090465 20056841
31. SPARC promotes pericyte recruitment via inhibition of endoglin-dependent TGF-beta1 activity. Rivera LB, Brekken RA, J Cell Biol 2011 193 7 1305 1319 10.1083/jcb.201011143 21708981
32. Regulation of angiogenesis by SPARC and angiostatin: implications for tumor cell biology. Jendraschak E, Sage EH, Semin Cancer Biol 1996 7 3 139 146 10.1006/scbi.1996.0019 8773299
33. SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix. Chlenski A, Liu S, Guerrero LJ, Yang Q, Tian Y, Salwen HR, Zage P, Cohn SL, Int J Cancer 2006 118 2 310 316 10.1002/ijc.21357 16052522 (Pubitemid 41779069)
34. Regulation of tumor angiogenesis by thrombospondin-1. Ren B, Yee KO, Lawler J, Khosravi-Far R, Biochim Biophys Acta 2006 1765 2 178 188 16406676
35. TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Seo DW, Li H, Guedez L, Wingfield PT, Diaz T, Salloum R, Wei BY, Stetler-Stevenson WG, Cell 2003 114 2 171 180 10.1016/S0092-8674(03)00551-8 12887919 (Pubitemid 36936911)
36. The role of angiopoietin-like proteins in angiogenesis and metabolism. Hato T, Tabata M, Oike Y, Trends Cardiovasc Med 2008 18 1 6 14 10.1016/j.tcm.2007.10.003 18206803
37. Biology of the apelin-APJ axis in vascular formation. Kidoya H, Takakura N, J Biochem 2012 152 2 125 131 10.1093/jb/mvs071 22745157
38. Interleukin-1alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion. Salven P, Hattori K, Heissig B, Rafii S, FASEB J 2002 16 11 1471 1473 12205052
39. CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A. Scapini P, Morini M, Tecchio C, Minghelli S, Di Carlo E, Tanghetti E, Albini A, Lowell C, Berton G, Noonan DM, Cassatella MA, J Immunol 2004 172 8 5034 5040 10.4049/jimmunol.172.8.5034 15067085 (Pubitemid 38456430)
40. Endogenous angiogenesis inhibitors: angiostatin, endostatin, and other proteolytic fragments. Cao Y, Prog Mol Subcell Biol 1998 20 161 176 10.1007/978-3-642-72149-6-8 9928530
41. Activin A inhibits vascular endothelial cell growth and suppresses tumour angiogenesis in gastric cancer. Kaneda H, Arao T, Matsumoto K, De Velasco MA, Tamura D, Aomatsu K, Kudo K, Sakai K, Nagai T, Fujita Y, Tanaka K, Yanagihara K, Yamada Y, Okamoto I, Nakagawa K, Nishio K, Br J Cancer 2011 105 8 1210 1217 10.1038/bjc.2011.348 21897392
42. Granulocyte colony-stimulating factor (G-CSF) depresses angiogenesis in vivo and in vitro: implications for sourcing cells for vascular regeneration therapy. Tura O, Crawford J, Barclay GR, Samuel K, Hadoke PW, Roddie H, Davies J, Turner ML, J Thromb Haemost 2010 8 7 1614 1623 10.1111/j.1538-7836.2010. 03900.x 20456757
43. G-CSF stimulates angiogenesis and promotes tumor growth: potential contribution of bone marrow-derived endothelial progenitor cells. Natori T, Sata M, Washida M, Hirata Y, Nagai R, Makuuchi M, Biochem Biophys Res Commun 2002 297 4 1058 1061 10.1016/S0006-291X(02)02335-5 12359263 (Pubitemid 35230360)
44. Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism. Brizzi MF, Battaglia E, Montrucchio G, Dentelli P, Del Sorbo L, Garbarino G, Pegoraro L, Camussi G, Circ Res 1999 84 7 785 796 10.1161/01.RES.84.7.785 10205146 (Pubitemid 29181485)
45. Matrix metalloproteinases and angiogenesis. Rundhaug JE, J Cell Mol Med 2005 9 2 267 285 10.1111/j.1582-4934.2005.tb00355.x 15963249
46. Oncostatin M induces angiogenesis in vitro and in vivo. Vasse M, Pourtau J, Trochon V, Muraine M, Vannier JP, Lu H, Soria J, Soria C, Arterioscler Thromb Vasc Biol 1999 19 8 1835 1842 10.1161/01.ATV.19.8.1835 10446061 (Pubitemid 29379912)
47. The murine CC chemokine, 6C-kine, inhibits tumor growth and angiogenesis in a human lung cancer SCID mouse model. Arenberg DA, Zlotnick A, Strom SR, Burdick MD, Strieter RM, Cancer Immunol Immunother 2001 49 11 587 592 10.1007/s002620000147 11225989 (Pubitemid 33783074)
48. Tissue inhibitor of metalloproteinases-1 (TIMP-1) inhibits tumor growth and angiogenesis in the TIMP-1 transgenic mouse model. Ikenaka Y, Yoshiji H, Kuriyama S, Yoshii J, Noguchi R, Tsujinoue H, Yanase K, Namisaki T, Imazu H, Masaki T, Fukui H, Int J Cancer 2003 105 3 340 346 10.1002/ijc.11094 12704667 (Pubitemid 36570046)
49. Leukemia inhibitory factor-transfected embryonic fibroblasts and vascular endothelial growth factor successfully improve the skin substitute wound healing by increasing angiogenesis and matrix production. Akita S, Daian T, Ishihara H, Fujii T, Akino K, J Dermatol Sci 2004 36 1 11 23 10.1016/j.jdermsci.2004.05.007 15488701 (Pubitemid 39370021)
50. Leukemia inhibitory factor (LIF) inhibits angiogenesis in vitro. Pepper MS, Ferrara N, Orci L, Montesano R, J Cell Sci 1995 108 Pt 1 73 83 7537748
51. Mesenchymal stem cell migration is regulated by fibronectin through alpha5beta1-integrin-mediated activation of PDGFR-beta and potentiation of growth factor signals. Veevers-Lowe J, Ball SG, Shuttleworth A, Kielty CM, J Cell Sci 2011 124 Pt 8 1288 1300 21429937
52. Multipotent PDGFRbeta-expressing cells in the circulation of stroke patients. Jung KH, Chu K, Lee ST, Bahn JJ, Jeon D, Kim JH, Kim S, Won CH, Kim M, Lee SK, Roh JK, Neurobiol Dis 2011 41 2 489 497 10.1016/j.nbd.2010.10.020 21074616
53. Stem cell factor/c-kit signaling promotes the survival, migration, and capillary tube formation of human umbilical vein endothelial cells. Matsui J, Wakabayashi T, Asada M, Yoshimatsu K, Okada M, J Biol Chem 2004 279 18 18600 18607 10.1074/jbc.M311643200 14985355 (Pubitemid 38623281)
54. Expression of stem cell factor/c-kit signaling pathway components in diabetic fibrovascular epiretinal membranes. Abu El-Asrar AM, Struyf S, Opdenakker G, Van Damme J, Geboes K, Mol Vis 2010 16 1098 1107 20596251
55. Isolation, characterization, differentiation, and application of adipose-derived stem cells. Kuhbier JW, Weyand B, Radtke C, Vogt PM, Kasper C, Reimers K, Adv Biochem Eng Biotechnol 2010 123 55 105 20091288
56. Altered angiogenesis and survival in human tumor-derived endothelial cells. Bussolati B, Deambrosis I, Russo S, Deregibus MC, Camussi G, FASEB J 2003 17 9 1159 1161 12709414
57. Human plasma membrane-derived vesicles halt proliferation and induce differentiation of THP-1 acute monocytic leukemia cells. Ansa-Addo EA, Lange S, Stratton D, Antwi-Baffour S, Cestari I, Ramirez MI, McCrossan MV, Inal JM, J Immunol 2010 185 9 5236 5246 10.4049/jimmunol.1001656 20921526
58. A filtration-based protocol to isolate human plasma membrane-derived vesicles and exosomes from blood plasma. Grant R, Ansa-Addo E, Stratton D, Antwi-Baffour S, Jorfi S, Kholia S, Krige L, Lange S, Inal J, J Immunol Methods 2011 371 1-2 143 151 21741384
59. A modification of the masson trichrome technique for routine laboratory purposes. Goldner J, Am J Pathol 1938 14 2 237 243 19970387